Insider Trading Arrangements |
3 Months Ended | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 30, 2024
shares
| |||||||||||||||||||||||||||||
Trading Arrangements, by Individual | |||||||||||||||||||||||||||||
Material Terms of Trading Arrangement | From time to time, our directors and officers may engage in open-market transactions with respect to their Company equity holdings for diversification or other personal reasons. All such transactions by directors and officers must comply with the Company’s Amended and Restated Securities Trading Policy, which requires that such transactions be in accordance with applicable U.S. federal securities laws that prohibit trading while in possession of material nonpublic information. Rule 10b5-1 under the Exchange Act provides an affirmative defense that enables directors and officers to prearrange transactions in the Company’s securities in a manner that avoids concerns about initiating transactions while in possession of material nonpublic information. The following table describes the contracts, instructions or written plans for the purchase or sale of Company securities adopted or terminated by our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) during the quarter ended March 30, 2024, that are or were, as the case may be, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). No “non-Rule 10b5–1 trading arrangements” (as defined by Item 408(c) of Regulation S-K) or other Rule 10b5-1 trading arrangements were entered into or terminated, nor were any such arrangements modified, by our directors or officers during such period.
(1) The plan duration was until the date listed in this column or such earlier date upon the completion of all trades under the plan or the occurrence of such other termination events as specified in the plan. (2) This Rule 10b5-1 Plan was originally adopted on May 11, 2023. (3)
Reflects shares that were proposed to be transferred by Ms. Winfrey as a gift to The Oprah Winfrey Charitable Foundation (the “Foundation”) and sold by the Foundation. |
||||||||||||||||||||||||||||
Rule 10b5-1 Arrangement Adopted | false | ||||||||||||||||||||||||||||
Non-Rule 10b5-1 Arrangement Adopted | false | ||||||||||||||||||||||||||||
Rule 10b5-1 Arrangement Terminated | true | ||||||||||||||||||||||||||||
Non-Rule 10b5-1 Arrangement Terminated | false | ||||||||||||||||||||||||||||
Non-Rule10b5-1 Arrangement Modified | false | ||||||||||||||||||||||||||||
Oprah Winfrey | |||||||||||||||||||||||||||||
Trading Arrangements, by Individual | |||||||||||||||||||||||||||||
Rule 10b5-1 Arrangement Adopted | true | ||||||||||||||||||||||||||||
Adoption Date | May 11, 2023 | ||||||||||||||||||||||||||||
Exercise Stock Option | Oprah Winfrey | |||||||||||||||||||||||||||||
Trading Arrangements, by Individual | |||||||||||||||||||||||||||||
Aggregate Available | 2,687,063 | ||||||||||||||||||||||||||||
Termination of Rule 10b5-1 Plan [Member] | |||||||||||||||||||||||||||||
Trading Arrangements, by Individual | |||||||||||||||||||||||||||||
Name | Oprah Winfrey | ||||||||||||||||||||||||||||
Title | Director | ||||||||||||||||||||||||||||
Trd Arr Action and Type of Plan | Termination of Rule 10b5-1 Plan | [1] | |||||||||||||||||||||||||||
Trd Arr Date of Action | Feb. 28, 2024 | ||||||||||||||||||||||||||||
Trd Arr Scheduled Expiration of Plan | Mar. 10, 2025 | [2] | |||||||||||||||||||||||||||
Termination of Rule 10b5-1 Plan [Member] | Oprah Winfrey | |||||||||||||||||||||||||||||
Trading Arrangements, by Individual | |||||||||||||||||||||||||||||
Aggregate Available | 925,780 | ||||||||||||||||||||||||||||
Termination of Rule 10b5-1 Plan [Member] | Foundation [Member] | |||||||||||||||||||||||||||||
Trading Arrangements, by Individual | |||||||||||||||||||||||||||||
Aggregate Available | 157,968 | [3] | |||||||||||||||||||||||||||
|